The authors report on a pilot double-blind comparison of buspirone with haloperidol in the treatment of agitation manifested by physical tension and motor activity in Alzheimer's disease (AD). A group of 26 nursing home residents underwent a 10-week comparison of 15 mg buspirone (n = 12) vs. 1.5 mg haloperidol (n = 14) per day. Tension and anxiety decreased to a greater extent in those patients who were treated with buspirone. Although it is not possible to draw definitive conclusions from a treatment study that does not include a placebo group, these findings suggest the potential value of further clinical research on buspirone in managing agitation in AD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00019442-199622430-00011 | DOI Listing |
Biomedicines
December 2023
Department of Pharmaceutical Sciences, Barry & Judy Silverman College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Ft. Lauderdale, FL 33328-2018, USA.
Neurosci Biobehav Rev
February 2024
Research Department of Primary Care and Population Health, Centre for Ageing and Population Studies, UCL, London, UK.
People living with dementia commonly experience anxiety, which is often challenging to manage. We investigated the effectiveness of treatments for the management of anxiety in this population. We conducted a systematic review and meta-analysis of randomised controlled trials, and searched EMBASE, CINAHL, MEDLINE and PsycInfo.
View Article and Find Full Text PDFVet Anaesth Analg
January 2024
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA.
Objective: To screen modulators of biogenic amine (BA) neurotransmission for the ability to cause fentanyl to decrease isoflurane minimum alveolar concentration (MAC) in cats, and to test whether fentanyl plus a combination of modulators decreases isoflurane MAC more than fentanyl alone.
Study Design: Prospective, experimental study.
Animals: A total of six adult male Domestic Short Hair cats.
Background: Olanzapine (OLA) is an atypical second-generation antipsychotic that exhibits significant pharmacokinetic variability. We retrospectively investigated the effects of age, sex, and specific comedications on OLA pharmacokinetics in Chinese patients with schizophrenia.
Methods: Data on sex, age, and OLA dosage and steady-state plasma concentrations of 386 patients with schizophrenia (who have received OLA or a comedication of OLA with a psychotherapeutic drug) were collected and analyzed.
Am J Drug Alcohol Abuse
November 2022
Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan.
Inhalant (e.g. toluene) misuse by adolescents has been linked to psychosis and persistent cognitive deficits.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!